Advertisement Advanced Proteome Therapeutics names new CFO - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Advanced Proteome Therapeutics names new CFO

Advanced Proteome Therapeutics, a developer of drug delivery and drug redevelopment technologies, has appointed Kenneth Phillippe as its new CFO.

Mr Phillippe will assume the position of CFO from Alexander Krantz, who has served as CFO since October 23, 2006. Mr Krantz will continue to act as president, CEO and secretary of the company.

Mr Phillippe currently serves as CFO of Exchequer Resource, and CFO and Secretary of Bold Ventures. In the past Mr Phillippe has served as a director and officer of Urodynamix Technologies, a Vancouver-based medical device company and CFO of Columbia Goldfields, a junior gold mining company.

Mr Krantz said: “We are delighted to have Ken Phillippe assume the role of CFO in light of his vast accounting experience and expertise.”